Diabetes Metabolic Syndrome and Obesity,
Journal Year:
2022,
Volume and Issue:
Volume 15, P. 755 - 765
Published: March 1, 2022
Emerging
evidence
has
revealed
that
gut
microbiota
plays
a
pivotal
role
in
the
pathogenesis
of
type
2
diabetes
mellitus
(T2DM)
and
diabetic
kidney
disease
(DKD).
However,
few
studies
have
used
metagenomic
sequencing
to
analyze
alterations
community
patients
with
early-stage
DKD.We
carried
out
fecal
samples
10
DKD
(DKD
group)
T2DM
who
appeared
be
less
prone
(non-DKD
group),
aiming
compare
composition
function
between
non-DKD
groups.The
microbial
group
was
significantly
different
from
group,
characterized
by
marked
increase
phylum
Proteobacteria,
genus
Selenomonadales,
Neosynechococcus,
Shigella,
Bilophila,
Acidaminococcus,
species,
Escherichia
coli,
Bacteroides
plebeius,
Megasphaera
elsdenii,
Acidaminococcus
unclassified,
Bilophila
wadsworthia.
The
amounts
species
Citrobacter
farmeri
Syntrophaceticus
schinkii
were
positively
correlated
urinary
albumin
creatinine
ratio
group.
Furthermore,
functional
analysis
based
on
dbCAN
KEGG
databases
showed
aberrant
lipopolysaccharide
(LPS)
biosynthesis
carbohydrate
metabolism
microbiome
group.Our
findings
provided
for
versus
These
data
may
contribute
more
comprehensive
understanding
pathological
mechanisms
DKD.
Life,
Journal Year:
2024,
Volume and Issue:
14(5), P. 559 - 559
Published: April 26, 2024
The
gastrointestinal
tract
is
home
to
trillions
of
diverse
microorganisms
collectively
known
as
the
gut
microbiota,
which
play
a
pivotal
role
in
breaking
down
undigested
foods,
such
dietary
fibers.
Through
fermentation
these
food
components,
short-chain
fatty
acids
(SCFAs)
acetate,
propionate,
and
butyrate
are
produced,
offering
numerous
health
benefits
host.
production
absorption
SCFAs
occur
through
various
mechanisms
within
human
intestine,
contingent
upon
types
fibers
reaching
specific
engaged
fermentation.
Medical
literature
extensively
documents
supplementation
SCFAs,
particularly
butyrate,
treatment
gastrointestinal,
metabolic,
cardiovascular,
gut-brain-related
disorders.
This
review
seeks
provide
an
overview
dynamics
involved
gut.
Additionally,
it
will
focus
on
roles
promoting
metabolic
health,
well
their
current
therapeutic
implications.
Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
162, P. 114620 - 114620
Published: March 31, 2023
There
is
emerging
evidence
that
microbiota
and
its
metabolites
play
an
important
role
in
helath
diseases.
In
this
regard,
gut
has
been
found
as
a
crucial
component
influences
immune
responses
well
immune-related
disorders
such
autoimmune
Gut
bacterial
dysbiosis
shown
to
cause
disease
altered
metabolite
synthesis,
leading
immunological
metabolic
dysregulation.
Of
note,
the
produce
short-chain
fatty
acids
(SCFAs)
acetate,
butyrate,
propionate,
remodeling
these
linked
pathophysiology
of
number
type
1
diabetes,
multiple
sclerosis,
inflammatory
bowel
disease,
rheumatoid
arthritis,
celiac
systemic
lupus
erythematosus.
review,
we
will
address
most
recent
findings
from
noteworthy
studies
investigating
impact
SCFAs
on
various
Critical Reviews in Food Science and Nutrition,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 20
Published: Jan. 8, 2024
Tryptophan
(TRP)
contributes
to
individual
immune
homeostasis
and
good
condition
via
three
complex
metabolism
pathways
(5-hydroxytryptamine
(5-HT),
kynurenine
(KP),
gut
microbiota
pathway).
Indole
propionic
acid
(IPA),
one
of
the
TRP
derivatives
pathway,
has
raised
more
attention
because
its
impact
on
metabolic
disorders.
Here,
we
retrospect
increasing
evidence
that
metabolites/IPA
derived
from
proteolysis
host
health
disease.
IPA
can
activate
system
through
aryl
hydrocarbon
receptor
(AHR)
and/or
Pregnane
X
(PXR)
as
a
vital
mediator
among
diet-caused
microbe
cross-talk.
Different
levels
in
systemic
circulation
predict
risk
NAFLD,
T2DM,
CVD.
is
suggested
alleviate
cognitive
impairment
oxidative
damage,
reduce
inflammation,
inhibit
lipid
accumulation
attenuate
symptoms
putatively
enhance
intestinal
epithelial
barrier,
maintain
homeostasis.
Now,
provide
general
description
relationships
between
various
physiological
pathological
processes,
which
support
an
opportunity
for
diet
intervention
diseases.
Frontiers in Microbiology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 7, 2025
Diabetes
mellitus
represents
a
significant
global
health
problem.
The
number
of
people
suffering
from
this
metabolic
disease
is
constantly
rising
and
although
the
incidence
heterogeneous
depending
on
region,
country,
economic
situation,
lifestyle,
diet
level
medical
care,
it
increasing
worldwide,
especially
among
youths
children,
mainly
due
to
lifestyle
environmental
changes.
pathogenesis
two
most
common
subtypes
diabetes
mellitus,
type
1
(T1DM)
2
(T2DM),
substantially
different,
so
each
form
characterized
by
different
causation,
etiology,
pathophysiology,
presentation,
treatment.
Research
in
recent
decades
increasingly
indicates
potential
role
gut
microbiome
initiation,
development,
progression
disease.
Intestinal
microbes
their
fermentation
products
have
an
important
impact
host
metabolism,
immune
system,
nutrient
digestion
absorption,
barrier
integrity
protection
against
pathogens.
This
review
summarizes
current
evidence
changes
microbial
populations
both
types
mellitus.
Attention
focused
abundance
specific
bacterial
groups
at
taxonomic
levels
humans,
shift
also
assessed
relation
geographic
location,
age,
antidiabetic
drug.
causal
relationship
between
bacteria
still
unclear,
future
studies
applying
new
methodological
approaches
broader
range
microorganisms
inhabiting
digestive
tract
are
urgently
needed.
would
not
only
provide
better
understanding
disease,
but
use
beneficial
species
probiotics
for
treatment
diabetes.
Cell Discovery,
Journal Year:
2025,
Volume and Issue:
11(1)
Published: March 17, 2025
Abstract
According
to
traditional
Chinese
medicine
(TCM)
constitutional
theory,
individuals
with
phlegm-dampness
constitution
(PDC)
are
at
increased
risk
for
metabolic
disorders.
Previous
studies
have
indicated
that
PDC
exhibit
gene
expression
changes
associated
disorders,
even
normal
indices.
However,
the
biological
mechanisms
underlying
these
remain
unclear.
The
gut
microbiota
has
recently
emerged
as
a
promising
avenue
elucidating
TCM
principles.
Here,
we
revealed
distinct
and
serum
metabolite
profiles.
A
decrease
in
phytosphingosine
was
scores
disorder
severity.
Subsequent
experiments
demonstrated
Flavonifractor
plautii
can
biosynthesize
phytosphingosine,
which
also
negatively
correlated
score.
Interestingly,
both
F.
levels
decreased
subjects
Fecal
transplantation
from
accelerated
development
of
disorders
mice.
supplementation
ameliorated
by
increasing
gut‒hepatic
axis.
Mechanistic
investigations
confirmed
directly
bind
hepatic
peroxisome
proliferator-activated
receptor
α
(PPARα)
activate
its
nuclear
transcription
activity,
thereby
regulating
downstream
related
glucose‒lipid
metabolism.
Our
research
indicates
product,
contributes
increases
their
susceptibility
These
findings
suggest
diagnosing
may
be
beneficial
identifying
at-risk
populations
among
apparently
healthy
individuals,
advancing
broader
field
prevention
integration.
Diabetes Research and Clinical Practice,
Journal Year:
2020,
Volume and Issue:
172, P. 108645 - 108645
Published: Dec. 24, 2020
The
microbiome
is
greatly
significant
for
immune
system
development
and
homeostasis.
Dysbiosis
in
gut
microbial
composition
function
linked
to
responses
the
of
metabolic
diseases,
including
diabetes
mellitus
(DM).
However,
skin
changes
diabetic
patients
their
role
DM
are
poorly
elucidated.
In
this
review,
we
summarize
recent
findings
about
association
between
microbiota
DM,
highlighting
roles
proinflammatory
status
DM.
Moreover,
although
there
evidence
that
connection
causes
same
activated
innate
response,
additional
studies
needed
explore
mechanism.
These
might
inform
future
prevention,
diagnosis
treatment.
Frontiers in Endocrinology,
Journal Year:
2021,
Volume and Issue:
12
Published: Oct. 19, 2021
Metagenomics
studies
have
shown
that
type
2
diabetes
(T2D)
is
associated
with
an
altered
gut
microbiota.
Whereas
different
microbiota
patterns
been
observed
in
independent
human
cohorts,
reduction
of
butyrate-producing
bacteria
has
consistently
found
individuals
T2D,
as
well
those
prediabetes.
Butyrate
produced
the
large
intestine
by
microbial
fermentations,
particularly
dietary
fiber,
and
serves
primary
fuel
for
colonocytes.
It
also
acts
histone
deacetylase
inhibitor
ligand
to
G-protein
coupled
receptors,
affecting
cellular
signaling
target
cells,
such
enteroendocrine
cells.
Therefore,
butyrate
become
attractive
drug
treatment
strategies
devised
increase
its
intestinal
levels,
example
supplementation
or
through
fecal
transplant
(FMT).
In
this
review,
we
provide
overview
current
literature
indicating
these
yielded
encouraging
results
short-term
benefits
humans,
but
long-term
improvements
glycemic
control
not
reported
so
far.
Further
are
required
find
effective
approaches
restore
levels
gut,
investigate
their
impact
on
glucose
regulation
T2D.
Frontiers in Immunology,
Journal Year:
2021,
Volume and Issue:
12
Published: Aug. 12, 2021
Type
2
diabetes
mellitus
(T2DM)
is
a
complex
disorder
comprehensively
influenced
by
genetic
and
environmental
risk,
research
increasingly
has
indicated
the
role
of
microbial
dysbiosis
in
T2DM
pathogenesis.
However,
studies
comparing
microbiome
characteristics
between
healthy
controls
have
reported
inconsistent
results.
To
further
identify
describe
intestinal
flora
patients,
we
performed
systematic
review
meta-analysis
stool
profiles
to
discern
explore
heterogeneity
among
7
(600
cases,
543
controls,
1143
samples
total).
Using
random
effects
model
fixed
model,
observed
significant
differences
beta
diversity,
but
not
alpha
individuals
with
controls.
We
identified
various
operational
taxonomic
unit
(OTUs)
bacterial
genera
odds
ratios
for
T2DM.
The
signatures
derived
from
single
study
stepwise
feature
selection
could
be
applied
other
studies.
By
training
on
multiple
studies,
improved
detection
accuracy
disease
specificity
also
discuss
relationship
T2DM-enriched
or
T2DM-depleted
probiotics
provide
new
ideas
prevention
improvement.